Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,009 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

UPLYFT For Lymphoma Survivors

NCT05080166

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

DZD8586 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (TAI-SHAN9)

NCT06539195

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Research Site Hefei, Anhui, China
  • Research Site Beijing, Beijing Municipality, China
  • Research Site Guangzhou, Guangdong, China
  • Research Site Nanning, Guangxi, China
View all 14 locations
View Trial Details
Completed

Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis

NCT05184088

Conditions
AL Amyloidosis, ATTR Amyloidosis, Amyloid Neuropathies, +23 more
Locations
  • St Luke's Hospital Kansas City, Kansas, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
  • University of Pittsburgh Pittsburgh, Pennsylvania, United States
  • University of Augsburg Augsburg, Germany
View all 14 locations
View Trial Details
Completed

Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission

NCT01503632

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 102 locations
View Trial Details
Completed

A Study of Belantamab Mafodotin in Patients With Relapsed or Refractory AL Amyloidosis

NCT04617925

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • Centre hospitalier Universitaire de Limoges - Limoges, France
  • University Hospital Heidelberg Heidelberg, Germany
  • General Hospital of Athens "Alexandra" Athens, Greece
  • Fondazione I.R.C.C.S Policlinico "San Matteo" Pavia, Italy
View Trial Details

Related conditions